One-year follow-up period after transumbilical thoracic sympathectomy for hyperhidrosis: Outcomes and consequences

Abstract

Transumbilical thoracic sympathectomy is an efficacious alternative to the conventional approach. This technique avoided the chronic pain and chest wall paresthesia associated with the chest incision. In addition, this novel procedure afforded maximum cosmetic benefits.

Management of hyperhidrosis

“…In further support of the transumbilical approach, patients who had received this intervention reported significantly greater satisfaction with cosmetic outcome as well (94.1% vs 71.9%; P =0.036) 74. In a subsequent study by Zhu et al,75 a 1-year follow-up was provided for 35 patients who had received transumbilical thoracic sympathectomy for palmar and/or axillary HH. At 1 year, a 97.1% success rate (34 of 35) for palmar HH was noted, and a 72.2% success rate (13 of 18) was reported for axillary HH 75.…”

“…Beyond the risk of CH following ETS, there is also concern about cosmetic outcome and risk of chronic chest wall pain and paresthesias 74,75. Although the thoracic wall approach with endoscopy involves the creation of relatively small incisions,75 the desire for a less invasive approach and interest in preventing intercostal nerve injury have driven new procedural innovations.…”

“…Although the thoracic wall approach with endoscopy involves the creation of relatively small incisions,75 the desire for a less invasive approach and interest in preventing intercostal nerve injury have driven new procedural innovations. Investigators in the People’s Republic of China have recently explored the possibility of using natural orifice access for thoracic sympathectomy in the treatment of HH and have shown promising preliminary results.…”

Up-to-date Treatments of Primary Hyperhidrosis with Focus on Sympathectomy and Sympathicotomy; A Narrative Review

“…CS is generally reported in 28-100% of cases during the early post-operation period, but 2 to 3 years after surgery its occurrence rate is reduced to 21%-47%. Although CS has a rather high prevalence, it is severe in only 0-14% of patients during the early postoperation period, and its severity declines with time (Table 1) [1,7,21,26,29,[33][34][35][36][37][38].…”

“…No paper was found that compared the transumbilical approach with transthoracic thoracoscopic surgery [1,7,21,28,29].…”